Clinical Trial Update: Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing nivolumab for safety and efficacy in oral proliferative verrucous leukoplakia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Leukoplakia
• Oral Proliferative Verrucous Leukoplakia

Drugs mentioned

• nivolumab (Opdivo) (nivolumab)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Leukoplakia, Oral | Phase 2 | Status: COMPLETED | Results posted: 2024-04-22